Page last updated: 2024-08-25

zoledronic acid and Bile Duct Cancer

zoledronic acid has been researched along with Bile Duct Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baroni, MC; Borghetti, AF; Desenzani, S; Morganti, MM; Romani, AA; Soliani, P	1

Other Studies

1 other study(ies) available for zoledronic acid and Bile Duct Cancer

Article	Year
The BH3-mimetic ABT-737 targets the apoptotic machinery in cholangiocarcinoma cell lines resulting in synergistic interactions with zoledronic acid. Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:3 Topics: Antineoplastic Agents; Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biphenyl Compounds; Cell Line, Tumor; Cholangiocarcinoma; Diphosphonates; Drug Delivery Systems; Drug Synergism; Gene Expression Regulation; Humans; Imidazoles; Nitrophenols; Piperazines; S Phase; Sulfonamides; Zoledronic Acid	2011

Article

Year

The BH3-mimetic ABT-737 targets the apoptotic machinery in cholangiocarcinoma cell lines resulting in synergistic interactions with zoledronic acid.

Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:3

Topics: Antineoplastic Agents; Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biphenyl Compounds; Cell Line, Tumor; Cholangiocarcinoma; Diphosphonates; Drug Delivery Systems; Drug Synergism; Gene Expression Regulation; Humans; Imidazoles; Nitrophenols; Piperazines; S Phase; Sulfonamides; Zoledronic Acid

2011